Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    12171812 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Efficacy and Safety of Fispemifene in the Treatment of Hypogonadal Men With Chronic Obstructive Pulmonary Disease That Are on Oral Glucocorticoid Therapy
Conditions: Hypogonadism;   Chronic Obstructive Pulmonary Disease
Intervention: Drug: Fispemifene

Indicates status has not been verified in more than two years